(Q53481089)

English

Raised circulating Neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering Neurokinin A indicates improved prognosis.

scientific article published on 2 June 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

Raised circulating Neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering Neurokinin A indicates improved prognosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

author name string

Joy Es Ardill

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

David R McCance

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

Wendy V Stronge

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

Brian T Johnston

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

publication date

2 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

Annals of Clinical Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

53

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

259-264

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Circulating markers for endocrine tumours of the gastroenteropancreatic tract

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Control of carcinoid syndrome with everolimus

1 reference

https://api.crossref.org/works/10.1177%2F0004563215592021

21 January 2018

Identifiers

10.1177/0004563215592021

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/26038607

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53481089&oldid=1299102846"